Related Experiment Video
Updated: Aug 12, 2025

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
Published on: March 8, 2022
The tumor-immune ecosystem in shaping metastasis
Yang Gao1,2,3, Jeffrey M Rosen2,3, Xiang H-F Zhang1,2,3,4
1Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas, United States.
Cancer metastasis is driven by complex interactions between tumor cells and immune cells. Understanding these interactions is key to developing new therapies and reducing cancer mortality.
Area of Science:
- Oncology
- Immunology
Background:
- Cancer metastasis is a leading cause of cancer-related mortality.
- Tumor cell and immune cell interactions are increasingly recognized as critical regulators of metastasis.
- A deeper understanding of these complex interactions is needed to develop effective anti-metastatic therapies.
Purpose of the Study:
- To review recent findings on the co-evolution of tumor cells and immune cells in promoting metastasis.
- To highlight the role of tumor-host immunological interactions in the formation of the premetastatic niche.
- To summarize how these interactions facilitate metastasis at major organ sites.
Main Methods:
- Literature review of recent research on cancer metastasis and tumor-immune cell interactions.
- Synthesis of findings on the mechanisms of immune cell recruitment by tumor cells.
- Analysis of the role of immunological interactions in premetastatic niche formation and organ-specific metastasis.
Main Results:
- Tumor cells recruit immune cells, which promote various stages of metastasis, including invasion, circulation survival, and colonization.
- Tumor-host immunological interactions create a premetastatic niche in distant organs, facilitating secondary tumor formation.
- Specific immune cell subsets and their interactions with tumor cells are crucial for organotropism of metastasis.
Conclusions:
- The intricate interplay between tumor cells and the immune system is a central driver of cancer metastasis.
- Targeting these tumor-immune cell interactions presents a promising therapeutic strategy to combat metastasis.
- Further research into these dynamic interactions is essential for advancing cancer treatment and improving patient outcomes.
More Related Videos
07:45Author Spotlight: A Model to Study the Systemic and Local Dynamics of CD8+ T Cells During LN Metastasis
Published on: January 26, 2024
07:44Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports
Published on: November 28, 2019
Related Concept Videos
The Tumor Microenvironment
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Tumor Immunotherapy